-
Mashup Score: 0Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer - 1 year(s) ago
PURPOSE Hormone receptor–positive (HR+) human epidermal growth factor receptor 2–negative (HER2–) endocrine-resistant metastatic breast cancer is treated with sequential single-agent chemotherapy with poor outcomes. Sacituzumab govitecan (SG) is a first-in-class antibody-drug conjugate with an SN-38 payload targeting trophoblast cell-surface antigen 2, an epithelial antigen expressed in breast…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscape - 3 year(s) ago
Two new antibody–drug conjugates (ADCs) containing a topoisomerase I inhibitor payload have recently emerged in the breast cancer (BC) treatment landscape. Sacituzumab govitecan-hziy (SG) is a first-in-class anti-trophoblast cell-surface antigen 2 ADC approved for pretreated metastatic triple-negative breast cancer (mTNBC) and trastuzumab deruxtecan (T-DXd) gained approval for human epidermal…
Source: Esmo OpenCategories: Hem/Oncs, Latest HeadlinesTweet-
Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the #breastcancer treatment landscape, targeting #Her-2. @ESMO_Open by @myESMO https://t.co/tkIKDk5MpX
-
-
Mashup Score: 0Modern Menopause Solutions - 4 year(s) ago
She did it, she said the M-word. And that’s what we’ll be talking about today, menopause. She did it, she said the M-word. And that’s what we’ll be ta…
Source: radiomd.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
There's a new narrative emerging around #Menopause What is it, and what does it mean to #aging women? Dr. Rebecca Dunsmoor-Su comes to #HER to what she's learned in her wide experience as an #obgyn in Seattle. https://t.co/bw6fbuUkNR https://t.co/DXyVIwJCXc
-
-
Mashup Score: 0What Are We Eating During This Pandemic? - 4 year(s) ago
Can you believe we’re going on 7 months of this pandemic mess? As we head into fall, it seems like some people are starting to head back to restaurant…
Source: radiomd.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Abbie Gelman returns to #HER to talk about diving into #comfortfood changing your diet for boosting #Immunity and navigating the grocery store in a #pandemic @ChefAbbieGellma is the author of The Mediterranean DASH Diet Cookbook. https://t.co/l3fNawVk8K https://t.co/d2fZ2slnm0
-
-
Mashup Score: 1How To Stay Positive As Aging Takes Its Tolls - 4 year(s) ago
No one wants to talk about aging, as everything heads south and changes on our bodies. But it’s a topic that Dr. Beth Frates loves to discuss! No one…
Source: radiomd.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
No one wants to talk about #aging as everything heads south and changes on our bodies. But it's a topic that @BethFratesMD & I share a passion about. Join us on #HER for a lively conversation, & see her breathtaking experiences on her #Her page. ( ; https://t.co/3FFChlQTva https://t.co/U2kTgJnDec
-
-
Mashup Score: 0A Mathematician's Manifesto for Rethinking Gender - 4 year(s) ago
Dr. Eugenia Cheng’s resume is stacked as high as it is versatile. It includes being a concert pianist, WSJ columnist, mathematician, and author. Dr. E…
Source: radiomd.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Dr. Eugenia Cheng comes to #HER to dish on how we think about math, separating character from #gender & the terminology to describe people outside of their gender stereotypes. She is the author of x+y: A Mathematician's Manifesto for Rethinking Gender. https://t.co/53cMocKl49 https://t.co/ow85doTzxQ
-
-
Mashup Score: 0Fertility Treatments are Now Company Business - 4 year(s) ago
We as women have been taught for ages to be quiet on certain topics. Especially things like fertility. And nowadays, we’re talking about this stuff mo…
Source: radiomd.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Rachel Feintzeig joins me on #HER to challenge to notion that fertility is a taboo topic. @RachelFeintzeig is the Work & Life columnist at The Wall Street Journal, writing about the intersection of jobs and everything else. https://t.co/t3xnjXvSBj https://t.co/J6oz0RvrL7
-
-
Mashup Score: 0Why Being Kind Helps You, Too—Especially Now - 4 year(s) ago
Life is frustrating right now, no doubt about it. Maybe you got mad at someone in the grocery store the other day for not wearing a mask, or gave some…
Source: radiomd.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Elizabeth Bernstein joins me again on #HER to discuss how #Covid is driving out #anger and how #kindness is the antidote -- and has a physiological affect on us. This podcast is based on one of her @WSJ articles, "Bonds." https://t.co/uVebwO4F5e https://t.co/HeLj8r64JM
-
-
Mashup Score: 0
Dr. Rita Colwell is a Distinguished University Professor both at the University of Maryland at College Park and at Johns Hopkins University Bloomberg…
Source: radiomd.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Dr. Rita Colwell, author of A Lab of One’s Own: One Woman’s Personal Journey through Sexism in Science, comes to #HER to share her stories. Colwell has authored or co-authored 17 books & 800+ scientific publications" https://t.co/Fr2TLjuv90 https://t.co/HtD3082Fsb
-
-
Mashup Score: 0Exercising In A Pandemic - 4 year(s) ago
The best place to be during this pandemic is outdoors (if you’re doing it correctly). The best place to be during this pandemic is outdoors (if you’re…
Source: radiomd.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Gretchen Reynolds joins me on #HER to discuss the new rules in exercising during the #pandemic where even the outdoors has its dangers. Reynolds writes "Phys Ed" column for The New York Times, as well as other magazines. https://t.co/hUcHzEpNrD https://t.co/djq5Yw86Vz
-
#SacituzumabGovitecan in Hormone Receptor–Positive/Human #EGFR2–Negative Metastatic #BreastCancer This very effective drug antibody conjugate can be very effective in this patient population! 👉https://t.co/NQkNz4oNl0 @Hoperugo @UCSFCancer #Her #PhaseIII https://t.co/I0o66zBwh5